Ark Therapeutics Group PLC Holding(s) in Company (9765J)
24 July 2013 - 12:44AM
UK Regulatory
TIDMAKT
RNS Number : 9765J
Ark Therapeutics Group PLC
23 July 2013
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
-----------------------------------------------
1. Identity of the issuer or the ARK THERAPEUTICS GROUP PLC
underlying issuer of existing shares
to which voting rights are attached:
--------------------------------------------------------------------- -------------------------------------------
2. Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
---------------------------------------------------------------------------------------------------------- ------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already
issued to which voting rights are attached X
---------------------------------------------------------------------------------------------------------- ------
An acquisition or disposal of instruments with similar
economic effect to qualifying financial instruments
---------------------------------------------------------------------------------------------------------- ------
An event changing the breakdown of voting rights
---------------------------------------------------------------------------------------------------------- ------
Other (please
specify):
------------------------- ------------------------------------------------------------------------------- ------
3. Full name of person(s) subject Smith and Williamson Holdings
to the notification obligation: Limited
--------------------------------------------------------------------- -------------------------------------------
4. Full name of shareholder(s) (if Detailed as per section 9
different from 3.):
--------------------------------------------------------------------- -------------------------------------------
5. Date of the transaction and date 05/07/2013
on which the threshold is crossed
or reached:
--------------------------------------------------------------------- -------------------------------------------
6. Date on which issuer notified: 08/07/2013
--------------------------------------------------------------------- -------------------------------------------
7. Threshold(s) that is/are crossed
or reached: 10%
--------------------------------------------------------------------- -------------------------------------------
8. Notified details:
------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- -------------------------------- ----------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights
Shares Voting
Rights
-------------- ----------------- ------------- ----------- -------------------------- -----------------------
Direct Direct Indirect Direct Indirect
-------------- --------- ------ -------- --- ----------- ---------- -------------- ------- --------------
Ordinary
GB0034251727 21,352,100 21,352,100 20,352,100 9.72%
----------------- ------------- ----------- ---------- -------------- ------- --------------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
Period may be
acquired if
the
instrument is
exercised/ converted.
------------------------- ---------------- ------------------------ -------------------------- ---------------
N/A N/A N/A N/A N/A
------------------------- ---------------- ------------------------ -------------------------- ---------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights
period refers to
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
20,352,100 9.72%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the voting
rights and/or the
financial instruments are effectively held, if applicable:
-----------------------------------------------------------------------
Smith & Williamson Nominees Limited, a subsidiary of Smith &
Williamson Investment Services Limited, a subsidiary of Smith
& Williamson Holdings Limited - 4,677,100 shares
Royal Bank of Scotland as custodian for Smith & Williamson Fund
Administration Ltd, a subsidiary of Smith & Williamson Investment
Services Limited, a subsidiary of Smith & Williamson Holdings
Limited - 1,000,000 shares
BNP Paribas as custodian for Smith & Williamson Investment Services
Limited, a subsidiary of Smith & Williamson Holdings Limited
- 675,000 shares
BNP Paribas Securities Services as custodian for Smith & Williamson
Investment Management (Ireland) Limited, a subsidiary of Smith
& Williamson Holdings Limited - 14,000,000 shares
Proxy Voting:
-----------------------------------------------------------------------
10. Name of the proxy holder: N/A
---------------------------------------------------- -----------------
11. Number of voting rights proxy N/A
holder will cease to hold:
---------------------------------------------------- -----------------
12. Date on which proxy holder will N/A
cease to hold voting rights:
---------------------------------------------------- -----------------
13. Additional information:
---------------------------------------------------- -----------------
14. Contact name: Not advised
---------------------------------------------------- -----------------
15. Contact telephone number: Not advised
---------------------------------------------------- -----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUOSSROUABUAR
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Premier Veterinary Group Plc (London Stock Exchange): 0 recent articles
More ARK Therapeutics News Articles